In this study, for the first time, we evaluated the protective effect of folic acid treatment on stroke by simultaneous consideration of MTHFR C677T genotypes and all platelet activation parameters in hypertensive patients, which has never been reported before. The gene discussed is MTHFR; the disease is stroke disorder.